Novartis India Ltd. - Announcement Under Regulation 30 - Update With Respect To A Newspaper Publication In Mint On July 12, 2018

This letter has a reference to a newspaper publication in Mint on July 12, 2018 regarding issuance of a show cause notice by drug licensing authority to Themis Medicare Limited (Themis), who is a manufacturer of Diclofenac 1 ml injection for Novartis India Limited (Company).

In this context, it may be noted that Themis has intimated the Company on July 12, 2018 that they are in receipt of a show cause notice dated July 11, 2018 from the drug licensing authority at Daman, wherein they were directed to not manufacture the said product until the matter is decided. (contd..)


Pdf Link: Novartis India Ltd. - Announcement Under Regulation 30 - Update With Respect To A Newspaper Publication In Mint On July 12, 2018

Source : BSE - www.bseindia.com

Published on July 12, 2018

Related

This article is closed for comments.
Please Email the Editor